An 11-year-old girl developed an asymptomatic rash on her face, arms, and legs that persisted for 3 weeks over the autumn, reported Samar Sheriff, MD, MBA, of the University of Louisville in Kentucky, ...
Sponsor Name: EMD Serono Research & Development Institute, Inc. Purpose of Study: The purpose of this Proof of Concept (PoC) and Dose-finding (DF) basket study is to evaluate the efficacy and safety ...
Most people with lupus have it affect the skin. The types of rashes can be divided into two large groups. First, when lupus affects the skin with problems only seen in lupus, it’s called cutaneous ...
ORLANDO, Fla. — A second phase 2 trial with the tyrosine kinase 2 (TYK2) inhibitor deucravacitinib has met the primary efficacy endpoints for the treatment of the skin manifestations of cutaneous ...
An ANA report has three parts: (1) a positive or negative result; (2) if positive, what the titer is; and (3) the pattern of fluorescence. ANA patterns. Titers and patterns can vary between laboratory ...
Telitacicept, a new dual inhibitor of the cytokines B-lymphocyte stimulator (BLyS) and APRIL (a proliferation-inducing ligand), showed efficacy in adults with active systemic lupus erythematosus (SLE) ...
Objectives To define a clinically meaningful treatment response definition for haemolytic anaemia, that will form part of a novel multidomain outcome measure for SLE clinical trials.Methods An ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results